1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > EU5 Infectious Diagnostics Market Outlook to 2021

EU5 Infectious Diagnostics Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 169 pages

EU5 Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, "EU5 Infectious Diagnostics Market Outlook to 2021", provides key market data on the EU5 Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the EU5 Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

EU5 Infectious Diagnostics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Infectious Diagnostics Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Infectious Diagnostics Market, EU5 11
3.1 Infectious Diagnostics Market, EU5, Revenue ($m), 2007-2021 11
3.2 Infectious Diagnostics Market, EU5, Category Comparison by Revenue ($m), 2007-2021 13
3.3 Infectious Diagnostics Market, EU5, Revenue ($m), 2007-2014 15
3.4 Infectious Diagnostics Market, EU5, Revenue ($m), 2014-2021 17
3.5 Infectious Diagnostics Market, EU5, Company Share by Revenue ($m), 2014 19
4 Infectious Diagnostics Market, France 21
4.1 Infectious Diagnostics Market, France, Revenue ($m), 2007-2014 21
4.2 Infectious Diagnostics Market, France, Revenue ($m), 2014-2021 23
4.2.1 Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), by Segment, 2007-2014 25
4.2.2 Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), by Segment, 2014-2021 27
4.3 Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), 2013-2014 29
4.4 Infectious Diagnostics Market, France, Company Share by Revenue ($m), 2014 30
5 Infectious Diagnostics Market, Germany 32
5.1 Infectious Diagnostics Market, Germany, Revenue ($m), 2007-2014 32
5.2 Infectious Diagnostics Market, Germany, Revenue ($m), 2014-2021 34
5.2.1 Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), by Segment, 2007-2014 36
5.2.2 Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), by Segment, 2014-2021 38
5.3 Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), 2013-2014 40
5.4 Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), 2014 41
6 Infectious Diagnostics Market, Italy 43
6.1 Infectious Diagnostics Market, Italy, Revenue ($m), 2007-2014 43
6.2 Infectious Diagnostics Market, Italy, Revenue ($m), 2014-2021 45
6.2.1 Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2007-2014 47
6.2.2 Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), by Segment, 2014-2021 49
6.3 Infectious Diagnostics Market, Italy, Distribution Share by Revenue ($m), 2013-2014 51
6.4 Infectious Diagnostics Market, Italy, Company Share by Revenue ($m), 2014 52
7 Infectious Diagnostics Market, Spain 54
7.1 Infectious Diagnostics Market, Spain, Revenue ($m), 2007-2014 54
7.2 Infectious Diagnostics Market, Spain, Revenue ($m), 2014-2021 56
7.2.1 Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2007-2014 58
7.2.2 Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2014-2021 60
7.3 Infectious Diagnostics Market, Spain, Distribution Share by Revenue ($m), 2013-2014 62
7.4 Infectious Diagnostics Market, Spain, Company Share by Revenue ($m), 2014 63
8 Infectious Diagnostics Market, United Kingdom 65
8.1 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2007-2014 65
8.2 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2014-2021 67
8.2.1 Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), by Segment, 2007-2014 69
8.2.2 Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), by Segment, 2014-2021 71
8.3 Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014 73
8.4 Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2014 74
9 Overview of Key Companies in EU5 Infectious Diagnostics Market 76
9.1 Abbott Laboratories 76
9.1.1 Company Overview 76
9.2 F. Hoffmann-La Roche Ltd. 76
9.2.1 Company Overview 76
9.3 Siemens Healthcare 76
9.3.1 Company Overview 76
9.4 Qiagen N.V. 77
9.4.1 Company Overview 77
9.5 DiaSorin S.p.A 77
9.5.1 Company Overview 77
9.6 Alere Inc. 77
9.6.1 Company Overview 77
9.7 Bio-Rad Laboratories, Inc. 78
9.7.1 Company Overview 78
9.8 bioMerieux S.A. 78
9.8.1 Company Overview 78
9.9 Becton, Dickinson and Company 78
9.9.1 Company Overview 78
9.10 Danaher Corporation 79
9.10.1 Company Overview 79
10 Infectious Diagnostics Market Pipeline Products 80
11 Recent Developments 94
11.1 Corporate Communications 94
11.1.1 Jun 25, 2015: Cardiac Dimensions Announces Initial Enrollments in REDUCE FMR Clinical Trial 94
11.1.2 Jun 18, 2015: Dutch hospital acquires 1,000th Agility, Elekta's radiotherapy beam-shaping technology for treating cancer 95
11.1.3 May 11, 2015: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer 96
11.1.4 May 08, 2015: Change in Roche Board of Directors 97
11.1.5 Mar 05, 2015: New Study in Journal of Tissue Viability Recognizes SEM Scanner's Clinical Utility in Detection of Pressure Ulcers 97
11.2 Financial Announcements 98
11.2.1 Aug 31, 2015: bioMerieux - First-Half 2015 Results 98
11.2.2 Aug 25, 2015: EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter 102
11.2.3 Aug 25, 2015: High Throughput Single-Cell mRNA Sequencing Preparation Comes to the Fluidigm C1 System 104
11.2.4 Aug 25, 2015: SPR Therapeutics Awarded $1.6M NIH Grant to Study Pain Management Following Knee Replacement Surgery Using the Sprint PNS System 105
11.2.5 Aug 25, 2015: Xtant Medical Announces FDA Approval of OsteoSelect PLUS 107
11.2.6 Aug 25, 2015: Multi-center ALS Study Using the NeuRx Diaphragm Pacing System Shows Safety and Survival Post-Implant of 20.9 Months 109
11.2.7 Aug 07, 2015: Interim financial report for Q2 2015 - the BioPorto Group 111
11.2.8 Jul 29, 2015: QIAGEN reports results for second quarter and first half of 2015 112
11.2.9 Jul 23, 2015: Roche delivers strong performance in the first half of 2015 117
11.2.10 May 05, 2015: QIAGEN Reports Results for First Quarter 2015 119
11.2.11 Apr 23, 2015: bioMerieux - First-Quarter 2015 Business Review 123
11.2.12 Apr 23, 2015: bioMerieux - First-Quarter 2015 Business Review 127
11.2.13 Apr 22, 2015: Roche reports strong sales growth in the first quarter of 2015 130
11.2.14 Mar 24, 2015: Biotest increases sales by 16.2% 134
11.2.15 Mar 19, 2015: AHN Offers Innovative Minimally-Invasive Surgical Procedure for Patients with Common, Yet Difficult to Diagnose, Form of Recurring Back Pain 134
11.2.16 Mar 18, 2015: Blue Belt Technologies Announces First Navio Case Performed in Australia and First Navio-assisted GRU Unicompartmental Knee Replacement 135
11.2.17 Mar 17, 2015: LG Health receives first upgrade to its CyberKnife M6 System 137
11.2.18 Mar 17, 2015: Mediware to Unveil CareTend Software at NHIA Conference 137
11.2.19 Mar 11, 2015: bioMerieux - 2014 Financial Results 139
11.2.20 Mar 03, 2015: Oxford Immunotec Reports Fourth Quarter and Full Year 2014 Financial Results 140
11.2.21 Feb 13, 2015: Biotest increases revenues significantly by 16.2% 142
11.2.22 Feb 12, 2015: FDA Classifies Previous Covidien Field Action for Its Trellis-6 Peripheral Infusion Systems As a Class 1 Recall 142
11.2.23 Dec 31, 2014: bioMerieux - Business Review for the Three Months and Full Year Ended December 31, 2014 143
11.2.24 Nov 12, 2014: Biotest Increases Sales By 11,5% Compared To Previous Year 146
11.3 Legal And Regulatory 146
11.3.1 Jun 30, 2015: ImmunID Receives Accreditation From College of American Pathologists 146
11.4 Other Significant Developments 147
11.4.1 Sep 11, 2015: For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices 147
11.4.2 Jul 17, 2015: bioMerieux - First-Half 2015 Business Review 147
11.4.3 May 07, 2015: Biotest increases revenues by 16,6% 150
11.4.4 Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche 151
11.4.5 Mar 18, 2015: THERADIAG reinforces its RD and production capacities in new state-of-the-art facility 151
11.4.6 Dec 15, 2014: SQI Diagnostics Wins Additional Business from UK-based Customer 152
11.4.7 Oct 23, 2014: £230 million for technologies to revolutionise research into disease 153
11.4.8 Sep 30, 2014: Biomerieux - Business Review for the Nine Months Ended September 30, 2014 154
11.5 Product News 158
11.5.1 Apr 27, 2015: NAT comments on the release of the first HIV self-test 158
11.5.2 Oct 22, 2014: m2p-labs Supports Research Project in Synthetic Biology 158
11.5.3 Oct 21, 2014: GENETWORx Launches a New Personal Health Panel for Advanced Diagnosis of Genital and Gastrointestinal Pathogens 158
11.6 Strategy And Business Planning 159
11.6.1 Sep 01, 2015: Mobidiag and Unilabs Enter into Agreement over Use of Amplidiag Product Line for Molecular Gastrointestinal Diagnostics 159
11.6.2 Aug 12, 2015: CINDE Announces Pharmaceutical Invested $5.5 Million for New Headquarters 160
11.6.3 Jul 01, 2015: Roche lays foundation stone of new IT innovation centre in Kaiseraugst 161
11.6.4 May 04, 2015: QIAGEN Partners With World's Largest Sequencing Provider 161
11.6.5 Apr 20, 2015: Curetis Expands Commercial Organization 162
11.6.6 Jan 19, 2015: Roche opens new Learning Center in Kaiseraugst 163
11.6.7 Oct 28, 2014: NovaBiotics Establishes a US Presence 163
11.6.8 Oct 10, 2014: bioMerieux Inaugurates A New Multidisciplinary RandD Center For Infectious Disease Diagnostics 164
12 Appendix 166
12.1 Research Methodology 167
12.1.1 Coverage 167
12.1.2 Secondary Research 167
12.1.3 Primary Research 167
12.1.4 Company Share Analysis 168
12.1.5 Distribution Share Analysis 168
12.2 GlobalData Consulting 168
12.3 Contact Us 168
12.4 Disclaimer 169

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021 12
Table 2: Infectious Diagnostics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021 14
Table 3: Infectious Diagnostics Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014 16
Table 4: Infectious Diagnostics Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021 18
Table 5: Infectious Diagnostics Market, EU5, Company Share by Revenue ($m), USD Constant, 2014 20
Table 6: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 22
Table 7: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 8: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 26
Table 9: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 28
Table 10: Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014 29
Table 11: Infectious Diagnostics Market, France, Company Share by Revenue ($m), USD Constant, 2014 31
Table 12: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 33
Table 13: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 35
Table 14: Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 37
Table 15: Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Table 16: Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 40
Table 17: Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 42
Table 18: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 44
Table 19: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 46
Table 20: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 48
Table 21: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 50
Table 22: Infectious Diagnostics Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 51
Table 23: Infectious Diagnostics Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 53
Table 24: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 55
Table 25: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Table 26: Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 59
Table 27: Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 61
Table 28: Infectious Diagnostics Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 62
Table 29: Infectious Diagnostics Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 64
Table 30: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 66
Table 31: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Table 32: Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 70
Table 33: Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 72
Table 34: Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014 73
Table 35: Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014 75
Table 36: Infectious Diagnostics Market Pipeline Products 80

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021 11
Figure 2: Infectious Diagnostics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021 13
Figure 3: Infectious Diagnostics Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014 15
Figure 4: Infectious Diagnostics Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021 17
Figure 5: Infectious Diagnostics Market, EU5, Company Share (%) 2014 19
Figure 6: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 21
Figure 7: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 8: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014 25
Figure 9: Infectious Diagnostics Rapid Tests and POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021 27
Figure 10: Infectious Diagnostics Market, France, Company Share (%) 2014 30
Figure 11: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 32
Figure 12: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 34
Figure 13: Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 36
Figure 14: Infectious Diagnostics Rapid Tests and POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Figure 15: Infectious Diagnostics Market, Germany, Company Share (%) 2014 41
Figure 16: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 43
Figure 17: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 45
Figure 18: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 47
Figure 19: Infectious Diagnostics Rapid Tests and POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 49
Figure 20: Infectious Diagnostics Market, Italy, Company Share (%) 2014 52
Figure 21: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 54
Figure 22: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Figure 23: Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 58
Figure 24: Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 60
Figure 25: Infectious Diagnostics Market, Spain, Company Share (%) 2014 63
Figure 26: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 65
Figure 27: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 67
Figure 28: Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014 69
Figure 29: Infectious Diagnostics Rapid Tests and POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021 71
Figure 30: Infectious Diagnostics Market, United Kingdom, Company Share (%) 2014 74

Companies mentioned
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Qiagen N.V.
DiaSorin S.p.A
Alere Inc.
Bio-Rad Laboratories, Inc.
bioMerieux S.A.
Becton, Dickinson and Company
Danaher Corporation

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information ...

2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.